Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Arachidonic acid metabolism,0.03966859664196275,7.140625,23.044192302242163,"['PLA2G6', 'CBR3']",0.8508119148078148,0,0,2
2,Linoleic acid metabolism,0.04228169560377199,46.14728682170543,145.98237395406238,['PLA2G6'],0.8508119148078148,0,0,1
3,alpha-Linolenic acid metabolism,0.04228169560377199,46.14728682170543,145.98237395406238,['PLA2G6'],0.8508119148078148,0,0,1
4,Glutathione metabolism,0.05545997378913809,5.798828125,16.770754353819452,"['RRM2', 'CHAC1']",0.8508119148078148,0,0,2
5,Glutamatergic synapse,0.07067771354853858,3.325084364454443,8.810226597305913,"['GNB4', 'SLC17A6', 'SLC38A2']",0.8508119148078148,0,0,3
6,Pentose and glucuronate interconversions,0.08278894286495077,15.377260981912144,38.31184243707238,['DCXR'],0.8508119148078148,0,0,1
7,Renin-angiotensin system,0.08278894286495077,15.377260981912144,38.31184243707238,['THOP1'],0.8508119148078148,0,0,1
8,Drug metabolism,0.08563978392867144,4.414434523809524,10.848937851213384,"['UCK1', 'RRM2']",0.8508119148078148,0,0,2
9,Pyrimidine metabolism,0.10561592776025715,3.8606770833333335,8.678593946590702,"['RRM2', 'UCK1']",0.8508119148078148,0,0,2
10,Acute myeloid leukemia,0.11253100636489284,3.705625,8.095035949231397,"['CCNA1', 'SPI1']",0.8508119148078148,0,0,2
11,Other glycan degradation,0.12159555533475148,9.223255813953488,19.4339060029541,['GBA2'],0.8508119148078148,0,0,1
12,GABAergic synapse,0.12669585613186046,3.4299768518518516,7.086215207992333,"['GNB4', 'SLC38A2']",0.8508119148078148,0,0,2
13,Glycosaminoglycan degradation,0.14038338150947222,7.684754521963824,15.088079191181814,['HYAL1'],0.8508119148078148,0,0,1
14,Nicotinate and nicotinamide metabolism,0.15877238908366867,6.585825027685493,12.119785906538098,['QPRT'],0.8508119148078148,0,0,1
15,Primary immunodeficiency,0.15877238908366867,6.585825027685493,12.119785906538098,['UNG'],0.8508119148078148,0,0,1
16,Fanconi anemia pathway,0.17677097933049504,5.761627906976744,9.98432664961163,['TOP3B'],0.8508119148078148,0,0,1
17,Synaptic vesicle cycle,0.18674266263828115,2.6424107142857145,4.434027923924281,"['SLC17A6', 'CPLX1']",0.8508119148078148,0,0,2
18,African trypanosomiasis,0.19438737806408524,5.120585701981051,8.38701918422564,['THOP1'],0.8508119148078148,0,0,1
19,Nicotine addiction,0.2116296391198832,4.607751937984496,7.155458700109019,['SLC17A6'],0.8508119148078148,0,0,1
20,Ether lipid metabolism,0.2116296391198832,4.607751937984496,7.155458700109019,['PLA2G6'],0.8508119148078148,0,0,1
21,Ras signaling pathway,0.22110964222761104,1.903030956746845,2.871857511912116,"['GNB4', 'FOXO4', 'PLA2G6']",0.8508119148078148,0,0,3
22,Metabolism of xenobiotics by cytochrome P450,0.24502312540686305,3.838501291989664,5.398478517580521,['CBR3'],0.8508119148078148,0,0,1
23,SNARE interactions in vesicular transport,0.26118963039662274,3.5426356589147288,4.756018775798949,['STX4'],0.8508119148078148,0,0,1
24,Homologous recombination,0.26118963039662274,3.5426356589147288,4.756018775798949,['TOP3B'],0.8508119148078148,0,0,1
25,Sphingolipid metabolism,0.26118963039662274,3.5426356589147288,4.756018775798949,['GBA2'],0.8508119148078148,0,0,1
26,Base excision repair,0.27701256395700363,3.2890365448504983,4.222111270472185,['UNG'],0.8508119148078148,0,0,1
27,Amino sugar and nucleotide sugar metabolism,0.29249917227729566,3.069250645994832,3.773009691391414,['CHIT1'],0.8508119148078148,0,0,1
28,Mineral absorption,0.29249917227729566,3.069250645994832,3.773009691391414,['STEAP2'],0.8508119148078148,0,0,1
29,Other types of O-glycan biosynthesis,0.29249917227729566,3.069250645994832,3.773009691391414,['COLGALT2'],0.8508119148078148,0,0,1
30,Transcriptional misregulation in cancer,0.2976618379256436,1.8829719387755102,2.2817801398068607,"['CCNA1', 'SPI1']",0.8508119148078148,0,0,2
31,Notch signaling pathway,0.3224916426018215,2.707250341997264,3.0637358081842754,['DLL1'],0.8508119148078148,0,0,1
32,Ferroptosis,0.3224916426018215,2.707250341997264,3.0637358081842754,['PCBP2'],0.8508119148078148,0,0,1
33,Glycerophospholipid metabolism,0.3370112511553257,2.5564168819982775,2.7804586064543266,['PLA2G6'],0.8508119148078148,0,0,1
34,Lysine degradation,0.3512220336914609,2.4214606283149736,2.533663076731368,['COLGALT2'],0.8508119148078148,0,0,1
35,RNA transport,0.36834599477793145,1.5883620689655173,1.58634894604229,"['SEH1L', 'GEMIN7']",0.8508119148078148,0,0,2
36,Vasopressin-regulated water reabsorption,0.3787430591127126,2.1901070505721667,2.126368908448195,['STX4'],0.8508119148078148,0,0,1
37,Th1 and Th2 cell differentiation,0.3920659326497455,2.0902043692741366,1.9571111449150678,['DLL1'],0.8508119148078148,0,0,1
38,Retrograde endocannabinoid signaling,0.39892616055263785,1.4848790322580645,1.3645725598200475,"['GNB4', 'SLC17A6']",0.8508119148078148,0,0,2
39,Cellular senescence,0.4064669812682355,1.461061507936508,1.3153243923299445,"['CCNA1', 'ZFP36L1']",0.8508119148078148,0,0,2
40,Antigen processing and presentation,0.4303570308942814,1.8384496124031007,1.550070609168666,['CD74'],0.8508119148078148,0,0,1
41,p53 signaling pathway,0.4425811048529908,1.7674418604651163,1.4406976118132913,['RRM2'],0.8508119148078148,0,0,1
42,Herpes simplex virus 1 infection,0.4531684101251222,1.2210298933872203,0.9664347285107497,"['CD74', 'ZNF486', 'ZFP28']",0.8508119148078148,0,0,3
43,Chemical carcinogenesis,0.4650544737093837,1.294674295774648,0.9912035891861316,"['PAQR8', 'DLL1']",0.8508119148078148,0,0,2
44,Olfactory transduction,0.46625372198488135,1.640642303433001,1.2518516271902593,['OR9Q1'],0.8508119148078148,0,0,1
45,Inflammatory mediator regulation of TRP channels,0.477713155049097,1.5838011226944668,1.1700248763440055,['PLA2G6'],0.8508119148078148,0,0,1
46,Amyotrophic lateral sclerosis,0.4995768370231654,1.1000855431993157,0.7634526177900846,"['KLC2', 'SEH1L', 'DNAH5', 'NEFH']",0.8508119148078148,0,0,4
47,Protein digestion and absorption,0.499904643734586,1.4811202800700176,1.0269168413362997,['SLC38A2'],0.8508119148078148,0,0,1
48,Human T-cell leukemia virus 1 infection,0.5134639162508327,1.1770833333333333,0.7846149376901628,"['CCNA1', 'SPI1']",0.8508119148078148,0,0,2
49,Morphine addiction,0.5211601799431734,1.3908856001879257,0.9064371376758976,['GNB4'],0.8508119148078148,0,0,1
50,Shigellosis,0.5267631553715436,1.147265625,0.7354021438074005,"['TNIP1', 'FOXO4']",0.8508119148078148,0,0,2
51,Pathways in cancer,0.5269041694499683,1.0608312689237545,0.6797134083589375,"['CCNA1', 'SPI1', 'GNB4', 'DLL1']",0.8508119148078148,0,0,4
52,Fc gamma R-mediated phagocytosis,0.5415189454756192,1.3109634551495017,0.8041151276711128,['PLA2G6'],0.8508119148078148,0,0,1
53,Circadian entrainment,0.5513738364574203,1.2743324720068907,0.7586639366853177,['GNB4'],0.8508119148078148,0,0,1
54,Alcoholism,0.561018493928907,1.2396815420071234,0.7165376767487851,['GNB4'],0.8508119148078148,0,0,1
55,Cell adhesion molecules,0.561018493928907,1.2396815420071234,0.7165376767487851,['CNTNAP1'],0.8508119148078148,0,0,1
56,Osteoclast differentiation,0.561018493928907,1.2396815420071234,0.7165376767487851,['SPI1'],0.8508119148078148,0,0,1
57,Ubiquitin mediated proteolysis,0.5704573687286658,1.2068543451652387,0.6774276657113876,['MID1'],0.8508119148078148,0,0,1
58,Vascular smooth muscle contraction,0.5887351081992739,1.1461240310077518,0.6071923603882322,['PLA2G6'],0.8508119148078148,0,0,1
59,Progesterone-mediated oocyte maturation,0.5975824148287343,1.1179807146908678,0.5756069851136886,['CCNA1'],0.8508119148078148,0,0,1
60,Serotonergic synapse,0.6062408263630258,1.0911775562938353,0.5461103267746836,['GNB4'],0.8508119148078148,0,0,1
61,AMPK signaling pathway,0.6147143453128244,1.0656210564268975,0.5185286466972888,['CCNA1'],0.8508119148078148,0,0,1
62,Relaxin signaling pathway,0.6230068899131355,1.0412262156448202,0.49270585146949253,['GNB4'],0.8508119148078148,0,0,1
63,Tuberculosis,0.6311222959683396,1.0179155900086132,0.4685013733029965,['CD74'],0.8508119148078148,0,0,1
64,Dopaminergic synapse,0.6311222959683396,1.0179155900086132,0.4685013733029965,['GNB4'],0.8508119148078148,0,0,1
65,Chemokine signaling pathway,0.6390643186845266,0.99561846983485,0.4457883435558363,['GNB4'],0.8508119148078148,0,0,1
66,Cholinergic synapse,0.6390643186845266,0.99561846983485,0.4457883435558363,['GNB4'],0.8508119148078148,0,0,1
67,Apelin signaling pathway,0.646836634247406,0.9742701632855022,0.4244520140539177,['GNB4'],0.8508119148078148,0,0,1
68,Cell cycle,0.646836634247406,0.9742701632855022,0.4244520140539177,['CCNA1'],0.8508119148078148,0,0,1
69,FoxO signaling pathway,0.6691709490712895,0.9153488372093024,0.36771001924236485,['FOXO4'],0.8508119148078148,0,0,1
70,Lysosome,0.6762996747739203,0.8972488220094239,0.3509310577909099,['HYAL1'],0.8508119148078148,0,0,1
71,Breast cancer,0.6832759457055911,0.8798449612403101,0.3350946557096547,['DLL1'],0.8508119148078148,0,0,1
72,mTOR signaling pathway,0.6832759457055911,0.8798449612403101,0.3350946557096547,['SEH1L'],0.8508119148078148,0,0,1
73,Purine metabolism,0.6901029975663386,0.8630978499341817,0.3201354390118603,['RRM2'],0.8508119148078148,0,0,1
74,Hepatocellular carcinoma,0.7097201815675258,0.8164451827242525,0.27994639588566617,['PHF10'],0.8631731937983422,0,0,1
75,Hepatitis B,0.7339720630661234,0.7614987080103359,0.2355196042317654,['CCNA1'],0.8711682739825355,0,0,1
76,Epstein-Barr virus infection,0.7397139598793049,0.7488880416825517,0.22578353494766903,['CCNA1'],0.8711682739825355,0,0,1
77,Kaposi sarcoma-associated herpesvirus infection,0.7453328566295027,0.7366841710427607,0.21652943304345368,['GNB4'],0.8711682739825355,0,0,1
78,Human immunodeficiency virus 1 infection,0.7614774207703634,0.7023255813953488,0.19138003939396997,['GNB4'],0.878627793196573,0,0,1
79,Viral carcinogenesis,0.776605871336892,0.6709986320109439,0.1696434183832455,['CCNA1'],0.8786463291009158,0,0,1
80,Axon guidance,0.7861585143148276,0.6516057585825028,0.15677428300663226,['EPHB3'],0.8786463291009158,0,0,1
81,Human cytomegalovirus infection,0.7907816961908242,0.6423190304618408,0.1507736874434353,['GNB4'],0.8786463291009158,0,0,1
82,Huntington disease,0.8493983974118876,0.592422385620915,0.09669929783363712,"['KLC2', 'DNAH5']",0.9307094900835743,0,0,2
83,Pathways of neurodegeneration,0.861890191336609,0.6156764495347172,0.09150639281300647,"['KLC2', 'DNAH5', 'NEFH']",0.9307094900835743,0,0,3
84,Endocytosis,0.8707694536170016,0.48853880136700845,0.0676030363088455,['ARFGAP1'],0.9307094900835743,0,0,1
85,Salmonella infection,0.8790034073011534,0.47302971576227393,0.06100498918711695,['KLC2'],0.9307094900835743,0,0,1
86,Human papillomavirus infection,0.9148787743931325,0.4043466223698782,0.03597217544409241,['CCNA1'],0.9483434305529118,0,0,1
87,PI3K-Akt signaling pathway,0.9167319828678147,0.4006997324552377,0.03483688502365297,['GNB4'],0.9483434305529118,0,0,1
88,Parkinson disease,0.9414800102292011,0.3500390601526351,0.021108112441864686,['KLC2'],0.9594025524232267,0,0,1
89,Prion disease,0.9487425240629686,0.334137238013207,0.01758157641280193,['KLC2'],0.9594025524232267,0,0,1
90,Alzheimer disease,0.9769193647984523,0.26216056938211163,0.006121754401952053,['KLC2'],0.9769193647984523,0,0,1
